Considering Asonor for snoring? Start with the product’s intended use, application method and precautions. This short buying guide helps you identify the information you need before making a decision. Check the product label and current instructions before use. What is Asonor intended to do? Asonor is a medical device intended to reduce snoring through local…
Archive: October 2014. Asonor was introduced in Toronto on 18 September 2014 during a Danish trade delegation headed by the then Crown Prince and Crown Princess of Denmark. The original TannerMedico announcement welcomed Canphar Inc., described at the time as part of the Risopharma Group, and BLUSKY-BEST.ca as partners for the Canadian market. These company…
This archive page records TannerMedico’s earlier announcement about Asonor’s coverage in the Scandinavian magazine Sund Nu. The announcement reported recognition for overall performance and value in a comparison of seven snoring products. What kind of comparison was described? The magazine comparison concerned consumer experiences with different product formats, including sprays, a mouthpiece, nasal strips and…
TannerMedico A/S will again be present at EXPOPHARM, Europe’s No 1 pharmaceutical exhibition and trade show, held in Düsseldorf Germany.
This historical article concerns a Swedish consumer-feedback initiative involving Asonor and the Buzzador community. The original announcement described volunteers using the product over approximately one month and answering a questionnaire, including observations from their partners. Feedback and clinical evidence answer different questions A willingness to recommend or continue using a product is a consumer-experience measure.…
This archive article concerns an earlier German consumer-feedback campaign involving Asonor and the Konsumgöttinnen community. TannerMedico’s original announcement described participants trying the product and reporting their experience. What consumer feedback can show Reports from participants and partners can help describe ease of use, acceptability and perceived changes in snoring. They do not, on their own,…
English
Arabic
Chinese (Simplified)
Canada
Danish
Dutch
French
German
Italian
Portuguese
Russian
Spanish
Asonor in Latin America: The 2015 Launch Announcement
Archive: September 2015. TannerMedico announced plans to introduce Asonor in Chile, followed by Peru, Colombia and Venezuela, through a partnership with Axon Pharma. The original announcement described a planned launch at the end of September 2015 and an intended expansion into Latin America. It is a historical record of those plans, not confirmation of present-day…
Read More